LEADER 03643nam  22005655  450 
001 9910158671703321
005 20200704021426.0
024 7 $a10.1007/978-4-431-56059-3
035   $a(CKB)3710000001008954
035   $a(DE-He213)978-4-431-56059-3
035   $a(MiAaPQ)EBC4778963
035   $a(PPN)198339135
035   $a(EXLCZ)993710000001008954
100   $a20170106d2017      u|         0
101 0 $aeng
135   $aurnn|008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCell Therapy Against Cerebral Stroke $eComprehensive Reviews for Translational Researches and Clinical Trials /$fedited by Kiyohiro Houkin, Koji Abe, Satoshi Kuroda
205   $a1st ed. 2017.
210  1$aTokyo :$cSpringer Japan :$cImprint: Springer,$d2017.
215   $a1 online resource (X, 156 p. 15 illus., 11 illus. in color.) 
311   $a4-431-56057-2 
311   $a4-431-56059-9 
320   $aIncludes bibliographical references.
327   $aPart I. Optimal Cell Sources  -- 1. Bone Marrow-Derived Mononuclear Cells  -- 2. Mesenchymal Stem Cells / Bone Marrow Stromal Cells  -- 3. Neural Stem Cells / Neuronal Progenitor Cells -- 4. iPS Cells / iN  -- Part II. Translational Research -- 5. Cell Culture -- 6. Cell Dose, Timing and Route -- 7. Scaffold -- 8. Cell Tracking  -- 9. Functional Bio-Imaging  -- Part III. Clinical Trials  -- 10. Review of Previous Clinical Trials and Guideline of Cell Therapy -- 11. Bone Marrow-Derived Mononuclear Cells -- 12. Mesenchymal Stem Cells.
330   $aThis book presents comprehensive reviews for both translational research and clinical trials on cell therapy for stroke. Cerebral stroke is still a leading cause of death and disability. However, despite intensive research, few treatment options are available. The therapeutic potential of cell transplantation has been studied for various pathological conditions of the central nervous system (CNS) including traumatic brain injury, traumatic spinal cord injury, degenerative disease, demyelinating disease and ischemic stroke, as the injured neural tissue in the CNS has only a limited regenerative capacity. Recently, a growing body of evidence in this field suggests that cell transplantation holds great potential as a form of stroke therapy. The authors, who are experts in the field of neurosurgery, review and discuss optimal cell sources and various issues involved in translational research; further, they outline ongoing clinical trials in Japan.
606   $aNervous system$xSurgery
606   $aNeurology
606   $aRegenerative medicine
606   $aTissue engineering
606   $aNeurosurgery$3https://scigraph.springernature.com/ontologies/product-market-codes/H39000
606   $aNeurology$3https://scigraph.springernature.com/ontologies/product-market-codes/H36001
606   $aRegenerative Medicine/Tissue Engineering$3https://scigraph.springernature.com/ontologies/product-market-codes/L16080
615  0$aNervous system$xSurgery.
615  0$aNeurology.
615  0$aRegenerative medicine.
615  0$aTissue engineering.
615 14$aNeurosurgery.
615 24$aNeurology.
615 24$aRegenerative Medicine/Tissue Engineering.
676   $a617.48
702   $aHoukin$b Kiyohiro$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aAbe$b Koji$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aKuroda$b Satoshi$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910158671703321
996   $aCell Therapy Against Cerebral Stroke$91552002
997   $aUNINA